Former Associated Press journalist and newsroom leader Paul Driscoll has died at the age of 91. Driscoll covered the civil ...
Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...
Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval for TAR-200, its investigational ...
Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...